Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Med Case Rep ; 15(1): 68, 2021 Feb 16.
Artigo em Inglês | MEDLINE | ID: mdl-33588921

RESUMO

BACKGROUND: Bertolotti's syndrome is widely known to cause low back pain in young patients and must be considered as a differential diagnosis. Its treatment such as conservative therapy or surgery remains controversial. Surgical procedure is recommended for intractable low back pain. The three-dimensional (3D) lumbosacral transitional vertebrae anatomy should be completely understood for a successful surgery. Using an intraoperative 3D navigation and preoperative preliminary surgical planning with a patient-specific 3D plaster model contribute for safe surgery and good outcome. CASE PRESENTATION: A case of a 22-year-old Japanese male patient with intractable left low back pain due to lumbosacral transitional vertebrae with Bertolotti's syndrome. The symptom resisted the conservative treatment, and anesthetic injection at pseudoarticulation only provided a short-term pain relief. Posterior resection using intraoperative three-dimensional (3D) navigation has been performed through microendoscopic view. Pseudoarticulation was totally and successfully resected in a safe manner. CONCLUSIONS: Preoperative surgical planning and rehearsal using a patient-specific 3D plaster model was greatly useful and effective for surgeons in performing accurate and safe pseudoarticulation resection.


Assuntos
Dor Crônica , Dor Lombar , Adulto , Humanos , Dor Lombar/diagnóstico por imagem , Dor Lombar/etiologia , Dor Lombar/cirurgia , Vértebras Lombares/diagnóstico por imagem , Vértebras Lombares/cirurgia , Masculino , Resultado do Tratamento , Adulto Jovem
2.
Int J Hematol ; 78(5): 457-60, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14704041

RESUMO

We describe successful unrelated cord blood transplantation in a 14-month-old boy with Wiskott-Aldrich syndrome. He had been suffering from recurrent cytomegalovirus (CMV) pneumonia. Ganciclovir was given pretransplantation and posttransplantation, and CMV antigenemia was monitored as a marker of reactivation. The conditioning regimen was cyclophosphamide, busulfan, and antithymocyte globulin. The patient received an HLA 1-locus-mismatched cord blood unit, and the total number of infused nucleated cells was 9.0 x 10(7)/kg. Neutrophil engraftment was achieved on day +20, and a platelet count greater than 50 x 10(9)/L was achieved on day +51. A normal lymphoproliferative response to phytohemagglutinin mitogen was detectable 7 months posttransplantation. Long-term use of ganciclovir prevented CMV reactivation and did not compromise engraftment.


Assuntos
Transplante de Células-Tronco de Sangue do Cordão Umbilical , Síndrome de Wiskott-Aldrich/terapia , Antivirais/uso terapêutico , Infecções por Citomegalovirus/complicações , Infecções por Citomegalovirus/tratamento farmacológico , Enterocolite/complicações , Ganciclovir/uso terapêutico , Histocompatibilidade , Humanos , Lactente , Masculino , Pneumonia por Pneumocystis/complicações , Doadores de Tecidos , Transplante Homólogo , Síndrome de Wiskott-Aldrich/complicações
3.
Int J Hematol ; 77(1): 75-81, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12568303

RESUMO

Granulocyte colony-stimulating factor (G-CSF) has been shown to affect the biochemical markers of bone metabolism, including serum bone alkaline phosphatase (BALP), serum osteocalcin, and urine deoxypyridinoline. To determine the association between bone resorption and formation and the G-CSF-induced mobilization of peripheral blood stem cells (PBSC), we examined these markers during mobilization in 19 healthy donors. The average (+/- SEM) serum BALP level before treatment was 81.6 +/- 17.0 IU/dL, and the level increased significantly to 117.7 +/- 15.8 IU/dL on day 5 of G-CSF administration (P < .0001). The urine deoxypyridinoline level before treatment was 12.3 +/- 2.4 nmol/mmol creatinine, and this level also increased significantly to 19.4 +/- 3.0 nmol/mmol creatinine on day 5 of G-CSF administration (P < .0001). In contrast, the average level of serum osteocalcin significantly decreased from 8.07 +/- 2.88 ng/mL to 1.53 +/- 0.18 ng/mL on day 5 (P = .0353). During G-CSF administration, we also studied the serum levels of various cytokines (IL-1beta, osteoclastogenesis inhibitory factor [OCIF], IL-6, tumor necrosis factor alpha, transforming growth factor beta, interferon-gamma, macrophage colony-stimulating factor) related to bone metabolism. Only the kinetics of OCIF were significantly affected. The serum level of OCIF increased immediately after the start of G-CSF administration and remained high during G-CSF administration. These results demonstrate that high-dose G-CSF affects bone metabolism and that OCIF may play a role in bone metabolism. Consistent with the notion that G-CSF affects bone metabolism, a significant correlation was observed between CD34+ cell yield and the increase in urine deoxypyridinoline but not for the changes in serum BALP and osteocalcin levels. This result suggests that bone resorption is either directly or indirectly related to the mobilization of PBSC by G-CSF.


Assuntos
Remodelação Óssea/efeitos dos fármacos , Fator Estimulador de Colônias de Granulócitos/farmacologia , Transplante de Células-Tronco de Sangue Periférico , Adolescente , Adulto , Fosfatase Alcalina/sangue , Aminoácidos/sangue , Biomarcadores/sangue , Criança , Pré-Escolar , Citocinas/sangue , Mobilização de Células-Tronco Hematopoéticas , Humanos , Osteocalcina/sangue
4.
Pediatr Blood Cancer ; 47(6): 846-50, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16534791

RESUMO

Malignant rhabdoid tumor (MRT) is a rare and highly aggressive tumor that primarily occurs in very young children. We report here a patient with a primary MRT of the orbit who received tandem high-dose chemotherapy and gamma-knife radiosurgery. Although the tumor was not completely removed, and the initial chemotherapy failed, the patient achieved long-term survival after this modality of treatment. This approach may be one to be further considered in patients with MRT.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias Orbitárias/terapia , Radiocirurgia , Tumor Rabdoide/terapia , Terapia Combinada , Relação Dose-Resposta a Droga , Humanos , Imuno-Histoquímica , Lactente , Imageamento por Ressonância Magnética , Masculino , Neoplasias Orbitárias/diagnóstico , Neoplasias Orbitárias/patologia , Valor Preditivo dos Testes , Prognóstico , Tumor Rabdoide/diagnóstico , Tumor Rabdoide/patologia , Resultado do Tratamento
5.
Transfusion ; 44(2): 262-7, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-14962318

RESUMO

BACKGROUND: It would be beneficial to be able to predict the cord blood (CB) cell yield from volunteer donors before cell processing. STUDY DESIGN AND METHODS: The maternal and neonatal factors that influence the total nucleated cell (TNC), CD34+ cell, and CFU-GM yields in CB collected for the Chugoku-Shikoku Cord Blood Bank were evaluated. RESULTS: In a univariate analysis, the volume of CB collected was significantly correlated with the TNC, CD34+ cell, and CFU-GM yields (p < 0.001). A longer cord (p < 0.001), larger placenta (p < 0.001), and bigger baby (p < 0.001) were associated with a greater volume of CB. A female baby (p < 0.05) and longer gestational age (p < 0.005) were associated with a higher TNC concentration. A younger maternal age (p < 0.05), larger birth weight (p < 0.001), shorter gestational age (p < 0.001), and shorter time from collection to processing (p < 0.05) were associated with a higher CD34+ cell concentration. A multivariate linear regression analysis was performed to predict the yield and determine first-level selection criteria to start processing when the volume of CB units was on the borderline. However, this formula might not be suitable for actual use. CONCLUSION: Maternal and neonatal factors appeared to affect CB cell yields. These findings might be useful for efficiently collecting more qualified CB units.


Assuntos
Armazenamento de Sangue/métodos , Sangue Fetal/citologia , Células-Tronco Hematopoéticas/citologia , Fatores Etários , Antígenos CD34/análise , Núcleo Celular , Feminino , Idade Gestacional , Células-Tronco Hematopoéticas/química , Humanos , Masculino , Idade Materna , Placenta , Valor Preditivo dos Testes , Gravidez , Análise de Regressão , Fatores Sexuais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA